Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 15;137(4):623-34.
doi: 10.1016/j.cell.2009.02.037.

A two-step model for colon adenoma initiation and progression caused by APC loss

Reid A Phelps  1 , Stephanie Chidester, Somaye Dehghanizadeh, Jason Phelps, Imelda T Sandoval, Kunal Rai, Talmage Broadbent, Sharmistha Sarkar, Randall W Burt, David A Jones
Affiliations

A two-step model for colon adenoma initiation and progression caused by APC loss

Reid A Phelps et al. Cell. .

Abstract

Aberrant Wnt/beta-catenin signaling following loss of the tumor suppressor adenomatous polyposis coli (APC) is thought to initiate colon adenoma formation. Using zebrafish and human cells, we show that homozygous loss of APC causes failed intestinal cell differentiation but that this occurs in the absence of nuclear beta-catenin and increased intestinal cell proliferation. Therefore, loss of APC is insufficient for causing beta-catenin nuclear localization. APC mutation-induced intestinal differentiation defects instead depend on the transcriptional corepressor C-terminal binding protein-1 (CtBP1), whereas proliferation defects and nuclear accumulation of beta-catenin require the additional activation of KRAS. These findings suggest that, following APC loss, CtBP1 contributes to adenoma initiation as a first step, whereas KRAS activation and beta-catenin nuclear localization promote adenoma progression to carcinomas as a second step. Consistent with this model, human FAP adenomas showed robust upregulation of CtBP1 in the absence of detectable nuclear beta-catenin, whereas nuclear beta-catenin was detected in carcinomas.

PubMed Disclaimer

Figures

Figure 1
Figure 1. KRAS promotes intestinal cell proliferation and nuclear localization of β-catenin following loss of APC
(A) apcmcr zebrafish embryos were injected at the one cell stage with KRAS mRNA. 72 hpf embryos were fixed, sectioned and stained for hematoxylin and eosin (H&E) (Row 1, sagital section; row 2, cross section), DNA (magenta- middle and bottom) and either PCNA (middle-green) or β-catenin (bottom- green). Overlapping expression is shown in white. (B) Protein lysates from 72 hpf embryos were subjected to western blot analysis for either V5-tag (top-left) and total RAS (bottom-left) or phospho-Erk (top-right) and vinculin (bottom-right). (C) Zebrafish harboring an integrated β-catenin TOPGFP reporter were injected with KRAS mRNA, APC morpholino or both. 72 hpf embryos were subjected to whole mount in situ hybridization for GFP. Boxes indicate the intestine (top) and arrows indicate the hindbrain (bottom). All images were captured using the same exposure and represent at least three independent experiments. (Scale Bar: 10μm)
Figure 2
Figure 2. KRAS and RAF1 are necessary for nuclear localization of β-catenin and intestinal cell proliferation following loss of APC
(A) apcmcr zebrafish embryos injected with constitutively active RAF1 or MEK1. 72 hpf embryos were stained for hematoxylin and eosin (H&E) staining (top), DNA (magenta-middle and bottom) and either PCNA (middle-green) or β-catenin (bottom-green). (B) SW-480 cells transfected with control, KRASG12V, RAF1 directed siRNA or DN-MEK1 constructs were stained for DNA (magenta) and β-catenin (green). (C) RNA was harvested and subjected to rt-PCR for Axin2. (D) SW-480 cells transfected with KRASG12V-specific siRNA were cotransfected with constitutively active KRAS, RAF1 or MEK1 and stained for DNA (magenta) and β-catenin (green). Overlapping expression is shown in white. All images were captured using the same exposure and represent three independent experiments. (Scale Bar: 10μm)
Figure 3
Figure 3. KRAS and RAF1 direct stabilized β-catenin to the nucleus
(A) WT and KRAS-injected zebrafish embryos treated with PGE2 were stained for DNA (magenta), PCNA (green) and β-catenin (green). (B) Human 293 cells were transfected with constitutively active KRAS, RAF1 or MEK1 and either DMSO (top) or PGE2 (bottom). Cells were stained for DNA (magenta) and β-catenin (green). (C) 293 cells treated with DMSO, PGE2 or PGE2 and leptomycin B were stained for DNA (magenta) and β-catenin (green). (D) 293 cells were transfected with control or KRAS- or RAF1-directed siRNA and treated with EGF and PGE2 or vehicle then stained for DNA (magenta) and β-catenin (green). (E) 293 cells were subjected to an MTT assay (*p<0.05 vs DMSO). Overlapping expression is shown in white. All images were captured using the same exposure and represent three independent experiments. (Scale Bar: 10μm)
Figure 4
Figure 4. KRAS/RAF1 Regulation of β-catenin requires the Activity of RAC1
(A, B) SW-480 cells transfected with vehicle or myc-tagged (A, S191A or S605A) or flag-tagged (B, S552A or S675A) β-catenin mutants were stained for DNA (magenta) and α-myc (A, green) or α-flag (B, green). (C) SW-480 cells were transfected with RAC1-directed siRNA, DN-RAC1, DN-Cdc42 or treated with the RAC1-specific inhibitor NSC23766 were stained for DNA (magenta) and β-catenin (green). (D) SW-480 cells were subjected to an MTT assay (*p<0.05 vs DMSO). (E) SW-480 cells were transfected with vehicle, KRASG12V-targeted siRNA, RAF1 siRNA or DN-MEK1 and subjected to a RAC1 activity assay. The western blot was probed for RAC1 (top). Control lysates were probed for total RAC1 (bottom). (F) SW-480 cells treated as above were stained for phospho-cJun. (G) Human 293 cells transfected with constitutively active RAC1 and treated with PGE2 or DMSO were stained for DNA (magenta) and β-catenin (green). All images were captured using the same exposure and are representative of at least three independent experiments. (Scale Bar: 10μm)
Figure 5
Figure 5. KRAS-mediated intestinal cell proliferation following loss of APC requires β-catenin
(A) Zebrafish embryos were injected with β-cateninS45A mRNA (left panel) along with KRAS mRNA (middle panel). Also shown is a representative image of the APC-KRAS embryo (right panel). At 72hpf, the embryos were fixed and photographed. (B) The percent cyclops was analyzed (*p<0.01 WT vs β-catenin-KRAS, **p<0.01 WT vs. APC-KRAS). (C) Protein was harvested from apcmcr embryos treated with DMSO or NS-398 and subjected to western blot analysis for β-catenin (top) or vinculin (bottom). (D) Wildtype uninjected or apcmcr embryos injected with KRAS mRNA treated with VEH (top) or NS-398 (bottom) were stained by H&E (WT-left, APC-KRAS-right) and for DNA (magenta), PCNA (green) and β-catenin (green). TOPGFP-APCmo-KRAS embryos were stained for GFP expression (purple). Boxes indicate the intestine. (E) SW-480 cells treated with DMSO or NS-398 were stained for DNA (magenta) and β-catenin (green). Protein lysates were subjected to western blot analysis for β-catenin (top) and vinculin (bottom). (F) Cells were subjected to MTT analysis (*p<0.05 vs DMSO). Overlapping expression is shown in white. All images were captured using the same exposure and represent at least three independent experiments. (Scale Bar: 10μm)
Figure 6
Figure 6. apc control of cellular fate and differentiation are mediated by ctbp1 and are β-catenin-independent
(A) Protein from 48 hpf apcmcr zebrafish embryos injected with either 6xHis-APC955-2075 or 6xHis-APC955-2075-AALP were subjected to western blot analysis for β-catenin (top), ctbp1 (second), 6xHis (third) or vinculin (bottom). (B) Embryos injected as above were fixed at 72 hpf and subjected to in situ hybridization for i-fabp. (C) apcmcr embryos were treated with DMSO or NS-398 or injected with ctbp1-directed morpholino in the presence or absence of NS-398. At 72 hpf, the embryos were fixed and subjected to in situ hybridization for i-fabp, NaPi, hoxa13a or evx1. All images are representative of at least three independent experiments.
Figure 7
Figure 7. JNK1 activation is coincident with nuclear accumulation of β-catenin in human tumor samples
FFPE human matched grossly uninvolved and adenoma samples obtained from FAP patients and unmatched sporadic carcinomas were stained to indicate DNA (magenta) and (A) CtBP (green), (B) β-catenin* (green) or (C) phospho-cJun (green) as an indicator of JNK activity. Overall, 20 patient matched grossly uninvolved and adenoma or unmatched carcinoma tissue samples were stained. Shown are two representative samples. All images were captured using the same exposure and overlapping expression is shown in white. *Note: a section from each of the β-catenin-stained adenomas was enlarged to the right. Each antibody was evaluated using serial sections. (Scale Bar: 5μm)
See this image and copyright information in PMC

References

    1. Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, Haag JD, Chen KS, Waller JL, Gould MN, et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci U S A. 2007;104:4036–4041. - PMC - PubMed
    1. Anderson CB, Neufeld KL, White RL. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A. 2002;99:8683–8688. - PMC - PubMed
    1. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–320. - PubMed
    1. Bienz M, Hamada F. Adenomatous polyposis coli proteins and cell adhesion. Curr Opin Cell Biol. 2004;16:528–535. - PubMed
    1. Blaker H, Scholten M, Sutter C, Otto HF, Penzel R. Somatic mutations in familial adenomatous polyps. Nuclear translocation of β-catenin requires more than biallelic APC inactivation. American journal of clinical pathology. 2003;120:418–423. - PubMed

Publication types

MeSH terms